Acarix (ACARIX.ST) Stock Price

Acarix Price

OMX·CLOSED
0.16
​
Market closed

Revenue has compounded at 35.8% per year over the past 8 years to 7.36 M SEK. Acarix's net margin stands at -653.3%, up from -1,377.7% several years earlier.

Acarix stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Acarix business model & stock analysis

Acarix AB generates revenue through the sale of its primary medical device, the CADScor System, which utilizes phonocardiography for coronary artery disease monitoring. The system is designed for use by physicians, nurses, and laboratory technicians in clinical settings, featuring a chest patch with a recording head positioned at the fourth left intercostal space and a sensor on the sternum. Patients undergo a two-minute heart sound recording guided by audio cues and display instructions, after which the CAD-score is calculated and displayed for diagnostic purposes. The company's business model relies on direct sales of the CADScor System to healthcare providers, including hospitals and diagnostic laboratories, where the device is used for non-invasive rule-out diagnosis of coronary artery disease. The system's unique phonocardiography technique and algorithm-based scoring provide a streamlined diagnostic process, reducing the need for more invasive procedures and appealing to medical professionals seeking efficient diagnostic tools.

Frequently asked questions about Acarix

Converted at the current exchange rate, the Acarix share trades at 0.01 EUR (0.16 SEK).

The Acarix share (ACARIX.ST) is listed on 3 stock exchanges, including: Frankfurt (7AC.F), Stockholm (ACARIX.ST).

The expected revenue of Acarix is 14.00 M SEK. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Acarix is 112.33 M SEK. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Acarix is currently 1.61. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Acarix stock.

The price-to-sales ratio (P/S) of Acarix is currently 12.88. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Acarix stock.

The Eulerpool Quality Score for Acarix is 5/10.

The ISIN of Acarix is SE0009268717. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Acarix is A2DJR2. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Acarix is ACARIX.ST. The ticker symbol is used to trade Acarix shares on the stock exchange.

Fair ValueTerminal
0.13 SEK
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
817,888.89 SEK
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website acarix.com
Country
Sweden
Currency
SEK
Initial public offering
Dec 19, 2016
ISIN
SE0009268717
Cusip
W1R03P105
Market capitalization
178.16 M SEKMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
1.59
P/Ee 2027
—
P/Ee 2028
—
P/Ee 2029
—
P/Se
12.88
EV/EBIT
—
P/B Ratio
4.67
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-125.99 %
Last updated Nov 12, 2026, 3:17 AM

Acarix Peer Group

Acarix Ticker

FRANKFURT · 7AC.FSTOCKHOLM · ACARIX.STSTOCKHOLM · ACARIX.ST

Acarix FIGI

ACARIX:SF · BBG00FB2F0X67AC:GR · BBG00FP2M3G67AC:GF · BBG00FP2M3H5ACARIS:PO · BBG00JL6Z397ACARISEK:X2 · BBG00JL72676ACARISEK:XB · BBG00JL72685ACARISEK:XH · BBG00JL726B1ACARISEK:XF · BBG00JL726D9ACARISEK:XE · BBG00JL726G6ACARISEK:XJ · BBG00JL726H5ACARISEK:XL · BBG00JL726J3ACARISEK:XG · BBG00JL726K1

All fundamentals and in-depth analysis of Acarix

Our stock analysis for Acarix stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Acarix. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.